PBI19 BUDGET IMPACT ANALYSIS OF IXEKIZUMAB, GUSELKUMAB, RISANKIZUMAB AND/OR SECUKINUMAB FOR MANAGEMENT OF MODERATE-TO-SEVERE PSORIASIS IN THE KINGDOM OF SAUDI ARABIA
Abstract
Authors
A. Al Jedai H. AL-Mudaiheem M. Aldail M. Fatani Y. Binamer Y. Sharma O. Mohamed N. Awad T. Al-Amaa